These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24069634)

  • 1. [Nicotine and neurologic diseases--even a noxious substance may possess beneficial properties].
    Kaakkola S; Tuominen R
    Duodecim; 2013; 129(16):1654-60. PubMed ID: 24069634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.
    LeSage MG; Shelley D; Ross JT; Carroll FI; Corrigall WA
    Pharmacol Biochem Behav; 2009 Jan; 91(3):461-7. PubMed ID: 18817808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does nicotine have beneficial effects in the treatment of certain diseases?
    Birtwistle J; Hall K
    Br J Nurs; 1996 Oct 24-Nov 13; 5(19):1195-202. PubMed ID: 9006184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
    Mihalak KB; Carroll FI; Luetje CW
    Mol Pharmacol; 2006 Sep; 70(3):801-5. PubMed ID: 16766716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varenicline disrupts prepulse inhibition only in high-inhibitory rats.
    Goktalay T; Buyukuysal S; Uslu G; Coskun AS; Yorgancioglu A; Kayir H; Uzbay T; Goktalay G
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():54-60. PubMed ID: 24632394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.
    Wecker L; Engberg ME; Philpot RM; Lambert CS; Kang CW; Antilla JC; Bickford PC; Hudson CE; Zesiewicz TA; Rowell PP
    Neuropharmacology; 2013 Oct; 73():75-86. PubMed ID: 23711550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats.
    Goutier W; Kloeze MB; McCreary AC
    Addict Biol; 2015 Mar; 20(2):248-58. PubMed ID: 24251901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
    Steensland P; Simms JA; Holgate J; Richards JK; Bartlett SE
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12518-23. PubMed ID: 17626178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine-motivated behavior in Caenorhabditis elegans requires the nicotinic acetylcholine receptor subunits acr-5 and acr-15.
    Sellings L; Pereira S; Qian C; Dixon-McDougall T; Nowak C; Zhao B; Tyndale RF; van der Kooy D
    Eur J Neurosci; 2013 Mar; 37(5):743-56. PubMed ID: 23351035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.
    Bito-Onon JJ; Simms JA; Chatterjee S; Holgate J; Bartlett SE
    Addict Biol; 2011 Jul; 16(3):440-9. PubMed ID: 21392178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
    Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.
    Biala G; Staniak N
    Pharmacol Biochem Behav; 2010 Aug; 96(2):141-7. PubMed ID: 20451547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-nicotinic therapies for smoking cessation.
    Siu EC; Tyndale RF
    Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW; Brooks PR; Vetelino MG; Wirtz MC; Arnold EP; Huang J; Sands SB; Davis TI; Lebel LA; Fox CB; Shrikhande A; Heym JH; Schaeffer E; Rollema H; Lu Y; Mansbach RS; Chambers LK; Rovetti CC; Schulz DW; Tingley FD; O'Neill BT
    J Med Chem; 2005 May; 48(10):3474-7. PubMed ID: 15887955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of brain and behavioral effects of varenicline and nicotine in rats.
    King J; Huang W; Chen W; Heffernan M; Shields J; Rane P; Bircher R; DiFranza JR
    Behav Brain Res; 2011 Sep; 223(1):42-7. PubMed ID: 21527291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area.
    Reperant C; Pons S; Dufour E; Rollema H; Gardier AM; Maskos U
    Neuropharmacology; 2010 Feb; 58(2):346-50. PubMed ID: 19887076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.
    Crunelle CL; Miller ML; Booij J; van den Brink W
    Eur Neuropsychopharmacol; 2010 Feb; 20(2):69-79. PubMed ID: 19959340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline improves mood and cognition during smoking abstinence.
    Patterson F; Jepson C; Strasser AA; Loughead J; Perkins KA; Gur RC; Frey JM; Siegel S; Lerman C
    Biol Psychiatry; 2009 Jan; 65(2):144-9. PubMed ID: 18842256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
    Turner JR; Castellano LM; Blendy JA
    J Pharmacol Exp Ther; 2010 Aug; 334(2):665-72. PubMed ID: 20435920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.